News

Cardinal Health Shares Surge as Company Elevates Full-Year Guidance After Strong Q2

Araverus Team|Thursday, February 5, 2026 at 7:49 PM

Araverus Team

Feb 5, 2026 · 7:49 PM

Cardinal Health · Earnings Outlook · Pharma Momentum · Stock Performance

Cardinal Health Earnings Outlook Pharma Momentum Stock Performance

Cardinal Health is expected to report its second-quarter fiscal results, with analysts anticipating a potential increase in full-year guidance following a previous boost.

Earnings per share are projected to decline compared to the last quarter.

Cardinal Health Shares Surge as Company Elevates Full-Year Guidance After Strong Q2

Read More On

Related Articles

Cigna Revenue Lifted by Growth in its Evernorth Unit

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

The U.S. economy looks healthy, but it crossed a threshold last year that’s concerning: All of the growth in jobs over a one-year period came in healthcare or social assistance. It’s a trend worth watching given cuts to government insurance programs. Read more in the Markets A.M. Newsletter

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Cardinal Health Shares Surge as Company Elevates Full-Year Guidance After Strong Q2

Read More On

Related Articles

Cigna Revenue Lifted by Growth in its Evernorth Unit

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

The U.S. economy looks healthy, but it crossed a threshold last year that’s concerning: All of the growth in jobs over a one-year period came in healthcare or social assistance. It’s a trend worth watching given cuts to government insurance programs. Read more in the Markets A.M. Newsletter

Boston Scientific Profit, Sales Rise but Issues Soft Guidance